Found 73 matching trials
Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma PHASE2 The main purpose of this trial is to investigate the effects of a new class...
Show More Location
Northwestern University
Learn More & Join Trial
Olaparib, Durvalumab, and Tremelimumab in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube or Primary Peritoneal Cancer With BRCA1 or BRCA2 Mutation PHASE2 This phase I/II trial studies the side effects and best dose of olaparib wh...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy PHASE3 This is a Phase 3, multi-national, open-label, 2-arm randomized study in pa...
Show More Learn More & Join Trial
Immunotherapy With Neo-adjuvant Chemotherapy for OVarian Cancer PHASE1 This is a randomized, open, comparative, multi-centre study which will recr...
Show More Location
Institut Ste Catherine
Learn More & Join Trial
Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and Tremelimumab PHASE1 The goal of this Phase 1b clinical trial is to evaluate the safety and effi...
Show More Status
Active Not Recruiting
Location
University of California, San Diego
Learn More & Join Trial
Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLC PHASE1 This is an open-label, multicenter, 2-arm study to evaluate the safety and ...
Show More Location
Research Facility
Learn More & Join Trial
Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable, Locally Advanced Liver Cancer PHASE1 This phase Ib trial investigates the side effects of durvalumab and tremeli...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies PHASE1 The investigators propose to evaluate the safety of drug combinations in pa...
Show More Location
University of Kansas Cancer Center
Learn More & Join Trial
Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers PHASE1 This phase I trial studies how well stereotactic body radiation therapy wor...
Show More Location
UT Southwestern/Simmons Cancer Center-Dallas
Learn More & Join Trial
Durvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to the Liver PHASE1 This pilot clinical trial studies the side effects and how well durvalumab ...
Show More Location
City of Hope Medical Center
Learn More & Join Trial